Bio-Techne (TECH) Receivables (2010 - 2026)

Bio-Techne's Receivables history runs 17 years deep, the most recent figure standing at $214.6 million for Q1 2026.

• In Q1 2026, Receivables fell 9.52% year-over-year to $214.6 million; the TTM figure through Mar 2026 stood at $214.6 million (down 9.52% YoY), while the FY2025 annual figure was $206.9 million, down 14.3% from the prior year.
• Receivables was $214.6 million for Q1 2026 at Bio-Techne, up from $184.6 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $241.4 million in Q2 2024 to a low of $174.2 million in Q3 2022.
• Historically, Receivables has averaged $208.3 million across 5 years, with a median of $207.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Receivables soared 33.82% in 2022, then dropped 17.79% in 2025.
• A 5-year view of Receivables shows it stood at $184.8 million in 2022, then gained by 12.28% to $207.5 million in 2023, then climbed by 5.06% to $217.9 million in 2024, then dropped by 15.29% to $184.6 million in 2025, then rose by 16.22% to $214.6 million in 2026.
• The last three Receivables figures came in at $214.6 million (Q1 2026), $184.6 million (Q4 2025), and $183.9 million (Q3 2025), per Business Quant data.